Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

MicroRNAs are crucial in controlling cell signaling, affecting cancer and tissue regeneration.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Dexpanthenol helps human hair follicle cells grow by preventing aging and death, and by supporting growth signals.

Drug repurposing shows promise for treating many medical conditions.

Hair follicles in people with alopecia have lower levels of a key blood vessel growth protein.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Substance from human umbilical cord blood cells promotes hair growth.

PDGF signaling is crucial for maintaining and renewing hair follicle stem cells, which could help treat hair loss.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

SCF and c-Kit decrease in AGA hair follicles, possibly affecting hair pigmentation and growth.

Different forms of FGF5 either promote or inhibit hair growth.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

Rat dermal papilla cells have unique genes crucial for hair growth.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

People with alopecia have shorter hair follicles and more c-kit, a stem cell factor receptor, which could predict how the condition progresses.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Nilotinib can cause generalized keratosis pilaris.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Activating the GDNF-GFRα1-RET signaling pathway could potentially promote skin and limb regeneration in humans and could be used to treat hair loss and promote wound healing.

Human skin acts like a hormone-producing organ, making and managing various hormones important for skin and hair health.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

STAT5 activation is crucial for starting the hair growth phase.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.